Upload
safetyjul
View
223
Download
0
Embed Size (px)
Citation preview
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
1/13
WHO GoodDistributionPractices for
PharmaceuticalProducts
WHO GoodDistributionPractices for
PharmaceuticalProducts
Presented by:
Director of Pharmacy AffairsU.S. Food and Drug Administration
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
2/13
M ap of
country:
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
3/13
3 |
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
4/13
4 |
HistoryHistoryOctober 2005: WHO GDP adopted by WHO Expert Committee on Specifications
for Pharmaceutical PreparationsNovember 2006: IMPACT decided to revise existing GDP to improve security of distribution chain vis--vis counterfeits
April 2007: IMPACT Regulatory Implementation Working Group met andidentified recommended edits
September 2007: Proposed revisions open for commentDecember 2007: Finalized by IMPACT General Meeting held in Lisbon
October 2008: Expert Committee reviewed document and recommendedmeeting of IMPACT and WHO
September 2009: Meeting of Experts
October 2009: Expert Committee adopted, pending consideration of outstandingcomments
October 31 2009: General comments due
November 2009: Expert Committee and IMPACT considering final comments
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
5/13
5 |
C ontentsC ontents
1. Introduction2. Scope of the document3. Glossary4. General principles
5. Regulation of the distributionof pharmaceutical products6. Organization and
management7. Personnel
8. Quality system9. Premises, warehousing and
storage10. Vehicles and equipment
11. Shipment containers andcontainer labeling
12. Dispatch13. Transportation and products
in transit14. Documentation15. Repackaging and relabelling16. Complaints17. Recalls18. Returned products19. Counterfeit pharmaceutical
products20. Importation21. Contract activities22. Self-inspection
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
6/13
6 |
Goals/ScopeGoals/Scope
Assist in ensuring the quality and identity of pharmaceutical products during all aspects of thedistribution process.
Revised to include particular situations andconsiderations related to preventing counterfeit medicinesfrom getting into the legitimate supply chain
Addresses only pharmaceutical products, but may beapplied to medical devices where appropriate Medical device GDPs in early stages of development by trade
organizations
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
7/13
7 |
Definition of distributionDefinition of distribution
The procuring, purchasing, holding, storing,selling, supplying, importing, exporting, or movement of pharmaceutical products, with theexception of the dispensing or providingpharmaceutical products directly to a patient or his or her agent
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
8/13
8 |
General principlesGeneral principles
All parties in distribution chain have a responsibility toensure the quality of the products and that the integrityof the distribution chain is maintained from themanufacturer to the entity responsible for dispensing
GDP principles should be included in nationallegislation and guidelines
Principles apply forward AND backward in the supply
chainCollaboration between regulators, law enforcement,customs agencies, manufacturers, distributors,pharmacies,
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
9/13
9 |
HighlightsHighlights
Regulation: Only authorized entities should be entitledto buy and sell pharmaceutical products
Personnel: All personnel should be trained and
qualified re: GDP requirementsDispatch: Specifies items to be included in dispatchnotices and procedures
Repackaging and relabeling: Should be limitedRecalls: Should be procedures for prompt recall of known or suspected defective or counterfeit products
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
10/13
10 |
Highlights: TraceabilityHighlights: Traceability
Shared responsibility across supply chain
Requirements to have a form of documentation thatcan be used to permit traceability of the products fromthe manufacturer/importer to the entity responsible for dispensing to the patient
A suitable and, to the extent possible, internationallycompatible product coding and identification systemshould be in place
Traceability vs. Pedigree
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
11/13
11 |
Highlights: C ounterfeit pharmaceuticalproducts
Highlights: C ounterfeit pharmaceuticalproducts
K eep suspect counterfeits apart and clearly labeled
Sale and distribution of suspect counterfeit productsshould be suspended and national regulatoryauthorities notified right away
When confirmed as counterfeit, a formal decisionshould be made re: disposal and ensuring that productdoes not re-enter the distribution system
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
12/13
12 |
N ext stepsN ext steps
HOPEFULLY .. It will be finalizedSOO N!!!!
8/3/2019 Who Good Distribution Practices for Pharmaceutical Products
13/13
1 3 |
Q uestions???Q uestions???